All funds

Brasada

Dec 2024 → Jun 2026 · Publishes quarterly · 4 funds

Our archive holds 7 letters from Brasada, behind 9 investment theses and positions in 3 companies. Every quote below is copied verbatim from the letter it came from.

Brasada’s own letters page
7
Letters
3
Companies
0
Moves
9
Theses

Companies held · 3

Every company Brasada has disclosed a position in across our archive, with the letter that last mentioned it.

Theses · 9

  • Fastenal is a mission-critical industrial supply-chain partner with pricing power, decentralized execution, reshoring tailwinds, and long-term expansion opportunities.

    Read the full thesis
  • Cavco Industries is a scaled manufactured-housing leader with oligopolistic structure, regulatory and zoning tailwinds, and a structural shortage-driven housing growth runway.

    Read the full thesis
  • June 2026

    Amphenol is a mission-critical interconnect leader with switching costs, decentralized execution, AI-driven growth, and long-term electrification and digitization tailwinds.

    Read the full thesis
  • Grupo Aeroportuario del Centro Norte is a Mexican airport operator benefiting from Monterrey-led nearshoring, traffic and commercial growth, resolved regulatory overhang, and an attractive valuation and dividend yield.

    Read the full thesis
  • September 2025

    Broadcom is positioned to be a leading player in AI and networking, benefiting from its custom AI chips, dominant software solutions, and strong market execution under CEO Hock Tan.

    Read the full thesis
  • September 2025

    Ferguson is the largest specialty distributor in North America for plumbing, HVAC, and waterworks, demonstrating resilience in revenue despite housing market weaknesses and showing potential for growth through strategic acquisitions and strong demand in non-residential sectors.

    Read the full thesis
  • June 2025

    Uber is a technology-driven marketplace connecting riders, drivers, restaurants, and shippers, with a robust business model that benefits from extensive data and dynamic pricing while embracing opportunities in autonomous vehicles for future growth.

    Read the full thesis
  • West Pharmaceutical’s steep sell-off masks a fundamentally resilient business with irreplaceable components, long-term tailwinds in biologics and GLP-1s, and a compelling setup for patient investors.

    Read the full thesis
  • March 2025

    Heico is a leading seller of PMA parts, strategically positioned for growth through acquisitions and potential opportunities with the US Military, while adopting a long-term investment approach.

    Read the full thesis

Letter archive · 7

Funds · 4

  • Brasada Capital3
  • Brasada CM3
  • Brasada Private Accounts1
  • Brasada0

Get Brasada’s next letter the day it lands

We track Brasada alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans
Share this fund